IBDEI0J2 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9312,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,9313,0)
 ;;=438.82^^64^649^50
 ;;^UTILITY(U,$J,358.3,9313,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9313,1,1,0)
 ;;=1^438.82
 ;;^UTILITY(U,$J,358.3,9313,1,2,0)
 ;;=2^DYSPHAGIA,LATE EFF OF CVA
 ;;^UTILITY(U,$J,358.3,9313,2)
 ;;=^317923
 ;;^UTILITY(U,$J,358.3,9314,0)
 ;;=787.20^^64^649^49
 ;;^UTILITY(U,$J,358.3,9314,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9314,1,1,0)
 ;;=1^787.20
 ;;^UTILITY(U,$J,358.3,9314,1,2,0)
 ;;=2^DYSPHAGIA NOS
 ;;^UTILITY(U,$J,358.3,9314,2)
 ;;=^335307
 ;;^UTILITY(U,$J,358.3,9315,0)
 ;;=787.29^^64^649^83
 ;;^UTILITY(U,$J,358.3,9315,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9315,1,1,0)
 ;;=1^787.29
 ;;^UTILITY(U,$J,358.3,9315,1,2,0)
 ;;=2^OTHER DYSPHAGIA
 ;;^UTILITY(U,$J,358.3,9315,2)
 ;;=^335280
 ;;^UTILITY(U,$J,358.3,9316,0)
 ;;=199.1^^64^649^77
 ;;^UTILITY(U,$J,358.3,9316,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9316,1,1,0)
 ;;=1^199.1
 ;;^UTILITY(U,$J,358.3,9316,1,2,0)
 ;;=2^METASTATIC CANCER
 ;;^UTILITY(U,$J,358.3,9316,2)
 ;;=^87705
 ;;^UTILITY(U,$J,358.3,9317,0)
 ;;=338.29^^64^649^33
 ;;^UTILITY(U,$J,358.3,9317,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9317,1,1,0)
 ;;=1^338.29
 ;;^UTILITY(U,$J,358.3,9317,1,2,0)
 ;;=2^CHRONIC PAIN NEC
 ;;^UTILITY(U,$J,358.3,9317,2)
 ;;=^334077
 ;;^UTILITY(U,$J,358.3,9318,0)
 ;;=338.4^^64^649^34
 ;;^UTILITY(U,$J,358.3,9318,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9318,1,1,0)
 ;;=1^338.4
 ;;^UTILITY(U,$J,358.3,9318,1,2,0)
 ;;=2^CHRONIC PAIN SYNDROME
 ;;^UTILITY(U,$J,358.3,9318,2)
 ;;=^334079
 ;;^UTILITY(U,$J,358.3,9319,0)
 ;;=585.1^^64^649^29
 ;;^UTILITY(U,$J,358.3,9319,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9319,1,1,0)
 ;;=1^585.1
 ;;^UTILITY(U,$J,358.3,9319,1,2,0)
 ;;=2^CHRO KIDNEY DIS STAGE I
 ;;^UTILITY(U,$J,358.3,9319,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,9320,0)
 ;;=585.2^^64^649^30
 ;;^UTILITY(U,$J,358.3,9320,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9320,1,1,0)
 ;;=1^585.2
 ;;^UTILITY(U,$J,358.3,9320,1,2,0)
 ;;=2^CHRO KIDNEY DIS STAGE II
 ;;^UTILITY(U,$J,358.3,9320,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,9321,0)
 ;;=585.3^^64^649^27
 ;;^UTILITY(U,$J,358.3,9321,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9321,1,1,0)
 ;;=1^585.3
 ;;^UTILITY(U,$J,358.3,9321,1,2,0)
 ;;=2^CHR KIDNEY DIS STAGE III
 ;;^UTILITY(U,$J,358.3,9321,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,9322,0)
 ;;=585.4^^64^649^28
 ;;^UTILITY(U,$J,358.3,9322,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9322,1,1,0)
 ;;=1^585.4
 ;;^UTILITY(U,$J,358.3,9322,1,2,0)
 ;;=2^CHR KIDNEY DIS STAGE IV
 ;;^UTILITY(U,$J,358.3,9322,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,9323,0)
 ;;=585.5^^64^649^31
 ;;^UTILITY(U,$J,358.3,9323,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9323,1,1,0)
 ;;=1^585.5
 ;;^UTILITY(U,$J,358.3,9323,1,2,0)
 ;;=2^CHRON KIDNEY DIS STAGE V
 ;;^UTILITY(U,$J,358.3,9323,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,9324,0)
 ;;=585.6^^64^649^52
 ;;^UTILITY(U,$J,358.3,9324,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9324,1,1,0)
 ;;=1^585.6
 ;;^UTILITY(U,$J,358.3,9324,1,2,0)
 ;;=2^END STAGE RENAL DISEASE
 ;;^UTILITY(U,$J,358.3,9324,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,9325,0)
 ;;=585.9^^64^649^32
 ;;^UTILITY(U,$J,358.3,9325,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9325,1,1,0)
 ;;=1^585.9
 ;;^UTILITY(U,$J,358.3,9325,1,2,0)
 ;;=2^CHRONIC KIDNEY DIS NOS
 ;;^UTILITY(U,$J,358.3,9325,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,9326,0)
 ;;=599.70^^64^649^60
 ;;^UTILITY(U,$J,358.3,9326,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9326,1,1,0)
 ;;=1^599.70
 ;;^UTILITY(U,$J,358.3,9326,1,2,0)
 ;;=2^HEMATURIA NOS
